Form 4 for TVGN Tevogen Inc.
Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-23 · accession 0001062993-24-021217 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-26 | 2024-12-23 | TVGN | Sordillo Victor J. | Dir | A - Grant | $0.00 | +480.0K | 577.0K | +495% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-23 | A | A | 240,000 | $0.00 | 336,962 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs") under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan. (F2) The RSUs, which were granted in recognition of the reporting person's past service on the Issuer's Board of Directors, vested in full immediately upon grant. |
| 2 | Common | Common Stock | 2024-12-23 | A | A | 240,000 | $0.00 | 576,962 | D | — | — | (F3) The RSUs will vest ratably in four equal annual installments beginning on January 1, 2025 provided that the reporting person remains in service with the Issuer at such dates. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |